Part D Enhanced Plans With Gap Coverage For Generics Increasing For 2011
Executive Summary
The number of enhanced stand-alone Medicare Part D plans offering to pay for generic drugs in the coverage gap will grow from 321 plans in 2010 to 341 plans in 2011, according to a preview of next year’s Part D landscape released by the Centers for Medicare and Medicaid Services Sept. 21.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
Medical Benefit, Hospital Drugs Exempt From Detailed Cost, Coverage Reporting In Final Rule
The most detailed US reporting requirements regarding prescription drug costs and coverage will target medicines reimbursed under the retail pharmacy benefit.
Pfizer Getting $529 Per Course For Paxlovid Under US Contract; Did Merck Drive A Harder Bargain?
US government is paying Merck & Co. around $181 more per course of treatment for its oral antiviral for COVID-19, molnupiravir, than it is to Pfizer for its competing drug.